Cue BiopharmaCUE 13F holders, Q2 2026 (June 30) 50 holders +48
49 new positions
1 sold out
2 famous investors
$31.56 avg. 13F price*
At the end of Q2 2026 , 50 institutions reported holding Cue Biopharma Inc. (CUE) in their 13F filings, up 48 from Q1 2026. 49 opened new positions and 1 sold out. The largest holders were Bleichroeder LP ($11.7M), Driehaus Capital Management LLC ($9.2M) and Vanguard Capital Management LLC ($5.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
Company Cue Biopharma Inc.
CUSIP 22978P205
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026 Institutions Total Value New Positions 49 $52.2M Exits 1 $46
All 13F filers, Q1 2026 → Q2 2026: 1,655,477 shares bought and 1,650 shares sold, net +1,653,827 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 50 holders Portfolio Manager % of Holder's Portfolio Change vs Q1 2026 Shares Value ▼ Bleichroeder LP 2.10% New 370,682 $11.7M Driehaus Capital Management LLC 0.05% New 292,144 $9.2M Vanguard Capital Management LLC 0.00% New 161,700 $5.1M Ikarian Capital, LLC 0.54% New 104,364 $3.3M Tetragon Partners GP Ltd 0.48% New 93,819 $3.0M Stempoint Capital LP 0.37% New 66,995 $2.1M BlackRock, Inc. 0.00% New 57,807 $1.8M ADAR1 Capital Management, LLC 0.08% New 55,193 $1.7M Lion Point Capital, LP 7.99% New 52,928 $1.7M Squadron Capital Management LLC 0.54% New 50,000 $1.6M Diadema Partners LP 0.58% New 48,369 $1.5M Geode Capital Management, LLC 0.00% New 47,824 $1.5M Boothbay Fund Management, LLC 0.02% New 31,459 $993K UBS Group AG 0.00% New 26,700 $843K Citadel Advisors 0.00% New 25,633 $809K Vanguard Fiduciary Trust Co. 0.00% New 24,476 $772K Texas Capital Bank Wealth Management Services Inc 0.04% New 22,881 $722K Renaissance Technologies 0.00% New 14,689 $464K State Street Corp. 0.00% New 14,176 $447K Persistent Asset Partners Ltd 0.12% New 12,332 $389K Robertson Stephens Wealth Management, LLC 0.01% New 11,133 $351K Susquehanna International Group, LLP 0.00% New 11,003 $347K Seven Fleet Capital Management LP 0.06% New 10,702 $338K Northern Trust Corp. 0.00% New 9,122 $288K Advisory Research Inc. 0.03% New 8,573 $271K Stifel Financial Corp. 0.00% New 8,218 $259K Angeles Wealth Management, LLC 0.01% New 7,000 $221K Bank of America Corp. 0.00% New 6,929 $219K Northwestern Mutual Wealth Management Co. 0.00% New 2,632 $83K Vanguard Global Advisers, LLC 0.00% New 1,637 $52K BNP Paribas Financial Markets 0.00% New 1,117 $35K Tower Research Capital LLC (TRC) 0.00% New 869 $27K Morgan Stanley 0.00% New 674 $21K Barclays PLC 0.00% New 479 $15K SBI Securities Co., Ltd. 0.00% New 300 $9K Gleason Group, Inc. 0.00% New 200 $6K Jones Financial Companies LLLP 0.00% New 213 $5K JPMorgan Chase & Co. 0.00% New 163 $5K NFSG Corp 0.00% New 99 $3K Golden State Wealth Management, LLC 0.00% New 66 $2K Tidemark, LLC 0.00% Reduce -96.7% 50 $2K Osaic Holdings, Inc. 0.00% New 48 $2K Physician Wealth Advisors, Inc. 0.00% New 33 $1K Mather Group, Llc. 0.00% New 33 $1K Group One Trading LLC 0.00% New 30 $947 Wells Fargo & Company 0.00% New 26 $821 IFP Advisors, Inc 0.00% New 3 $95 Citigroup Inc. 0.00% New 1 $32 Caitong International Asset Management Co., Ltd 0.00% New 1 $32 Royal Bank of Canada 0.00% New 2 $0
"% of holder's portfolio" is CUE's weight in each manager's 13F, not the share of Cue Biopharma Inc. the manager owns.